Danaher (DHR) Other Operating Expenses (2009 - 2020)
Danaher (DHR) posted Other Operating Expenses of $400000.0 for Q4 2020, down 99.91% on a QoQ basis from $455.0 million in Q3 2020.
Analysis
Danaher (DHR) Other Operating Expenses (2009 - 2020) Analysis & Trends
Danaher has reported Other Operating Expenses for 3 years, with the latest figure at $400000.0 in Q4 2020.
- On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $400000.0 in Q4 2020; TTM through Oct 2021 was $400000.0, a 99.91% decrease from a year earlier, with the FY2020 full-year figure at $455.0 million, changed N/A from the prior year.
- Other Operating Expenses was $400000.0 for Q4 2020 at Danaher, down from $455.0 million in the prior quarter.
- The five-year high for Other Operating Expenses was $455.0 million in Q3 2020, with the low at $400000.0 in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 400,000.00 |
| Jul 3, 2020 | 455.00 Mn |
| Apr 2, 2010 | 1.61 Bn |
| Oct 2, 2009 | 85.12 Mn |
| Jul 3, 2009 | 1.41 Bn |
| Apr 3, 2009 | 1.37 Bn |